3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Sponsor
Interventions
Nivolumab
5
pembrolizumab
4
Temozolomide
3
Radiotherapy
3
Magnetic Resonance Spectroscopy
3
Rituximab
2
Radiosurgery
2
Paclitaxel
2
Neoadjuvant Therapy
2
Ipilimumab
2
Gemcitabine
2
Fluorodeoxyglucose F18
2
Dexamethasone
2
Cyclophosphamide
2
Cisplatin
2
Carboplatin
2
Biopsy
2
Bevacizumab
2
venetoclax
1
theanine
1
temsirolimus
1
tafasitamab
1
sugemalimab
1
senicapoc
1
semaglutide
1
sacituzumab govitecan
1
prednylidene
1
pirtobrutinib
1
perampanel
1
paricalcitol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
ibritumomab tiuxetan
×
30 days
×
Clear all
No trials found.